Publications
- Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group2023 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, Faculty of Medicine in Pilsen
- Other malignancies in the history of CLL: an international multicenter study coducted by ERIC, the European Research Initiative on CLL, in HARMONY2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first-line therapy administration in patients with chronic lymphocytic leukemia2023 | Faculty of Medicine in Hradec Králové
- Modern approach to the treatment of chronic lymphocytic leukemia2023 | Faculty of Medicine in Hradec Králové
- Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index2022 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
- Severe secondary immune thrombocytopenia in a patient with chronic lymphocytic leukemia2022 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králov é
- External validation of International Prognostic Score for asymptomatic early stage chronic lymphocytic leukaemia and proposal of an alternative score2021 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia2021 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Low-dose fludarabine and cyclophosphamide combined with rituximab in the first-line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long-term results of project Q-lite by the Czech CLL Study Group2021 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
Loading network view...